Patent decision search
60 results found
| BL Number | Application / Patent Number | Person(s) or Company(s) involved | Hearing Officer | Decision Date |
|---|---|---|---|---|
| O/0023/26 | SPC/GB17/071 | DANA-FARBER CANCER INSTITUTE, INC. & GENETICS INSTITUTE LLC | Dr R Dinham | 15 January 2026 |
| O/1160/25 | EP1210428, SPC/GB17/072 | DANA-FARBER CANCER INSTITUTE, INC. & GENETICS INSTITUTE LLC | Dr R Dinham | 12 December 2025 |
| O/0705/25 | EP3632448, SPC/GB22/021 | Laboratorias Leon Farma SA | Dr R Dinham | 31 July 2025 |
| O/0600/25 | EP(UK) 2934479, SPC/GB20/032 | Boehringer Ingelheim Vetmedica GmbH | Dr R Dinham | 1 July 2025 |
| O/1016/24 | EP2081595, SPC/GB19/057, SPC/GB19/059, SPC/GB19/060, SPC/GB20/035, SPC/GB21/070 , SPC/GB21/071 | Genmab A/S | Dr R Dinham | 24 October 2024 |
| O/0257/24 | SPC/GB15/047, SPC/GB16/039 | Halozyme, Inc. | Dr L Cullen | 27 March 2024 |
| O/0484/23 | EP05823474.1, SPC/GB18/007 | Merck Serono S.A. | Mrs M Taylor | 26 May 2023 |
| O/1053/22 | EP1613296 , SPC/GB15/046 | Newron Pharmaceuticals S.p.A | Dr L Cullen | 1 December 2022 |
| O/711/22 | EP2464382B1, SPC/GB17/055 | Roche Glycart AG | Dr L Cullen | 23 August 2022 |
| O/242/22 | EP2330129, SPC/GB17/023 | Janssen Biotech, Inc | Dr L Cullen | 18 March 2022 |
| O/136/22 | EP1809343B1, SPC/GB14/029 | Ethicon, Inc., & Omrix Biopharmaceuticals, Inc | Dr L Cullen | 16 February 2022 |
| O/019/22 | EP(UK)1787639B1, SPC/GB11/051 | Chiesi Farmaceutici S.P.A. | Dr L Cullen | 11 January 2022 |
| O/732/21 | SPC/GB17/076 | Erber Aktiengesellschaft | Dr L Cullen | 5 October 2021 |
| O/610/20 | SPC/GB17/075 | Erber Aktiengesellschaft | Dr L Cullen | 4 December 2020 |
| O/321/20 | SPC/GB12/034 | Chugai Seiyaku Kabushiki Kaisha & Tadamitsu Kishimoto | Dr L Cullen | 11 June 2020 |
| O/111/20 | SPC/GB07/012 | Genentech, Inc. and Master Data Center, Inc. | Mr B Micklewright | 21 February 2020 |
| O/580/18 | EP(UK)0736030B1, SPC/GB06/007 | Merck Sharp & Dohme Corporation | Dr L Cullen | 19 September 2018 |
| O/410/16 | SPC/GB09/046 | Abraxis BioScience LLC | Dr J Houlihan | 26 August 2016 |
| O/117/16 | EP(UK)0720599B1, SPC/GB14/062 | Merck Sharp & Dohme Corporation | Dr L Cullen | 12 January 2016 |
| O/466/15 | SPC/GB14/030, SPC/GB14/031 | Angiotech Pharmaceuticals Inc. & University of British Columbia (UBC) | Dr L Cullen | 6 October 2015 |
| O/098/15 | SPC/GB/04/039 | Otsuka Pharmaceuticals Company Limited | Dr L Cullen | 4 March 2015 |
| O/552/14 | SPC/GB13/069 | Icahn School of Medicine at Mount Sinai | Dr L Cullen | 19 December 2014 |
| O/328/14 | SPC/GB10/51 | Leibniz-Institut für Neue Materialien Gemeinnützige GmbH | Dr L Cullen | 29 July 2014 |
| O/141/14 | SPC/GB/07/043 , SPC/GB/07/044 | Cerus Corporation | Dr L Cullen | 31 March 2014 |
| O/418/13 | SPC/GB/04/031 | Genzyme Corporation | Dr L Cullen | 22 October 2013 |
| O/506/12 | SPC/GB/08/046, SPC/GB/11/043 | GlaxoSmithKline | Mrs C L Davies | 19 December 2012 |
| O/495/12 | SPC/GB/09/057 | Genzyme Corporation | Patrick Purcell | 11 December 2012 |
| O/146/12 | SPC/GB/09/059 | AstraZeneca AB | Dr L Cullen | 2 April 2012 |
| O/252/11 | SPC/GB/99/033 | The Administrators of the Tulane Education Fund | Mr B Micklewright | 20 July 2011 |
| O/335/10 | SPC/GB/07/014, SPC/GB/07/015, SPC/GB/07/016, SPC/GB/07/017, SPC/GB/07/021, SPC/GB/07/081, SPC/GB/07/082, SPC/GB/07/084 | University of Queensland & CSL Limited | Dr L Cullen | 24 September 2010 |
| O/271/10 | SPC/GB/06/019 | Sankyo Company Limited | Dr L Cullen | 5 February 2010 |
| O/066/10 | SPC/GB/04/037 , SPC/GB/04/038 | Imclone Systems Inc. Ltd & Aventis Holdings Inc. | Dr L Cullen | 23 February 2010 |
| O/401/09 | SPC/GB 07/069, SPC/GB 07/070, SPC/GB 07/071, SPC/GB 07/073, SPC/GB 07/075, SPC/GB 07/078, SPC/GB 07/079 , SPC/GB 07/080 | Georgetown University (for SPC/GB 07/070, SPC/GB 07/071, SPC/GB 07/073, SPC/GB 07/078, SPC/GB 07/079 and SPC/GB 07/080); Loyola University of Chicago (for SPC/GB 07/069 only); University of Rochester (for SPC/GB 07/075 only) | Dr L Cullen | 29 December 2009 |
| O/384/09 | SPC/GB/07/051 | Neurim Pharmaceuticals (1991) Ltd | Mrs C L Davies | 15 December 2009 |
| O/357/09 | SPC/GB/09/015, SPC/GB/09/016, SPC/GB/09/017, SPC/GB/09/018, SPC/GB/09/019 | Medeva B.V. | Dr L Cullen | 16 November 2009 |
| O/096/09 | SPC/GB/95/010 | E I du Pont de Nemours & Co., Inc | Dr L Cullen | 9 April 2009 |
| O/052/09 | SPC/GB/06/002 | Astellas Pharma Inc | Mr L Cullen | 20 February 2009 |
| O/050/09 | SPC/GB/01/013 | Massachusetts Institute of Technology (MIT) | Mr L Cullen | 20 February 2009 |
| O/035/09 | SPC/GB/02/002 | Merck & Co., Inc | Dr L Cullen | 6 February 2009 |
| O/108/08 | SPC/GB07/046 | Merck & Co., Inc | Mr A C Howard | 14 April 2008 |
| O/006/08 | SPC/GB05/041 | Gilead Sciences, Inc | Mr A C Howard | 10 January 2008 |
| O/160/07 | GB0309527.0, GB0309529.6, GB0309531.2, GB0409603.8, GB0509026.1 | Phillip Raymond Michael Denne v Electro Magnetic Rams Ltd | Mr D J Barford | 11 June 2007 |
| O/360/06 | GB2370525 | Leisure Pleasure Products Ltd v Raymond Robert Britner | Mr D J Barford | 13 December 2006 |
| O/142/06 | GB2378382, PCT/GB2003/000293 | Ernest Ogden v John McKenzie and Projectile Limited | Mr D J Barford | 8 June 2006 |
| O/296/05 | GB2352475, GB2362428 | Bio Pure Technology Ltd v (1) Jarzon Plastics Ltd and (2) Anthony Elliot | Mr P Hayward | 3 November 2005 |
| O/138/05 | SPC/GB/01/051 | Knoll AG | Mr R Walker | 19 May 2005 |
| O/087/05 | GB2352475, GB2362428 | Bio Pure Technology Ltd v (1) Jarzon Plastics Ltd and (2) Anthony Elliott | Mr P Hayward | 31 March 2005 |
| O/360/04 | SPC/GB/03/036 | Peptech Limited | Mr R Walker | 9 December 2004 |
| O/222/04 | SPC/GB/02/023 | Yissum Research & Development Company of the Hebrew University of Jerusalem | Mr R Walker | 29 July 2004 |
| O/086/04 | AU4631799, EP99929525.6, GB9814507.1, PCT/GB99/02090 | I.D.A. Limited et al v University of Southampton et al | Mr S N Dennehey | 31 March 2004 |
| O/044/03 | SPC/GB/99/012 | Novartis AG and Universtiy College London; Novartis AG and Institute of Microbiology and Epidemiology | Mr R Walker | 12 February 2003 |
| O/022/03 | SPC/GB/02/004 | Eli Lilly and Company | Mr R Walker | 27 January 2003 |
| O/302/02 | SPC/GB/97/080 | Abbott Laboratories | Mr R Walker | 25 July 2002 |
| O/275/02 | SPC/GB/98/010 | H. Lundbeck A/S | Mr R Walker | 10 July 2002 |
| O/229/02 | SPC/GB/96/030, SPC/GB/96/035 | Takeda Chemical Industries Limited | Mr R Walker | 31 May 2002 |
| O/002/02 | SPC/GB/96/030, SPC/GB/96/035 | Takeda Chemical Industries Limited | Mr R Walker | 6 December 2001 |
| O/274/00 | SPC/GB/99/018 | Innovata Biomed Ltd | Mr D L Wood | 10 August 2000 |
| O/232/00 | SPC/GB99/031 | Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute and Teijin Ltd | Mr D L Wood | 6 July 2000 |
| O/217/00 | SPC/GB/98/050 | Booker Aquaculture Ltd | Mr D L Wood | 15 March 2000 |
| O/216/00 | SPC/GB/98/049 | Booker Aquaculture Ltd | Mr D L Wood | 15 March 2000 |
